Blue Mountain Achieves SOC 2 Compliance, Demonstrating Commitment to Data Security and Trustworthiness
10 avr. 2024 09h00 HE
|
Blue Mountain
STATE COLLEGE, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Blue Mountain, the leader in GMP-compliant EAM (Enterprise Asset Management) software for life sciences, proudly announces its achievement of...
Indegene Hosts Inaugural Strategic Advisory Board Meeting Chaired By Renowned Global Biopharma Leader Jill DeSimone
02 avr. 2024 07h00 HE
|
Indegene Inc
Indegene Hosts Inaugural Strategic Advisory Board Meeting Chaired By Renowned Global Biopharma Leader Jill DeSimone
Empire State Development Announces 10 Startups Selected For Round Seven of Luminate NY
28 mars 2024 13h07 HE
|
Luminate
Empire State Development announces the companies selected to participate in cohort seven of Luminate NY's business accelerator and investment fund.
Indegene acquires Trilogy Writing & Consulting GmbH, a medical writing consultancy
27 mars 2024 23h43 HE
|
Indegene Inc
Indegene acquires Trilogy Writing & Consulting GmbH, a medical writing consultancy
ON Partners Report Reveals Executive Women Secure Higher Base Salaries Than Men
27 mars 2024 12h28 HE
|
ON Partners
CLEVELAND, March 27, 2024 (GLOBE NEWSWIRE) -- This month, ON Partners, a pure-play retained executive search firm building C-level and board leadership teams, released its 2024 Women’s Report in...
Intelligencia AI Ranks No. 90 on Inc. Magazine’s List of the Northeast Region’s Fastest-Growing Private Companies
20 mars 2024 09h18 HE
|
Intelligencia AI
Inc. magazine recently revealed that Intelligencia AI, a provider of AI-powered decision-making solutions for the pharmaceutical industry, ranks No. 90.
MasterControl Generative AI-Powered Exam Builder Beta Program Kicks Off
27 févr. 2024 10h00 HE
|
MasterControl
Effective training programs are vital to quality teams. With MasterControl’s AI-powered Auto Exam Builder, quality professionals save significant time.
BioNTX Champions Talent Retention in the Texas Life Sciences Industry
15 févr. 2024 10h00 HE
|
Bio North Texas
DALLAS, Feb. 15, 2024 (GLOBE NEWSWIRE) -- BioNTX, the leading biotechnology and healthcare innovation trade organization in North Texas, continues its commitment to nurturing the thriving, regional,...
Kneat Announces Closing of $20 Million Bought Deal Including Full Exercise of Over-Allotment Option
14 févr. 2024 09h04 HE
|
kneat.com, inc.
Kneat announced the closing of its bought deal: it issued 6,153,880 common shares at $3.25 per share for gross proceeds of $20,000,110.
Kneat to Announce 2023 Fourth-Quarter and Fiscal Year Financial Results February 21, 2024
13 févr. 2024 17h12 HE
|
kneat.com, inc.
Kneat will announce its Q4 2023 results on February 21, 2024 after market close and host a call for investors the following morning.